Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon Expands Toronto Facility | Contract Pharma
Breaking News

Patheon Expands Toronto Facility

Patheon is expanding its Toronto manufacturing facility, adding 10,000 sq. ft. of GMP space dedicated to the production of oral contraceptives.


Patheon is expanding its Toronto manufacturing facility, adding 10,000 sq. ft. of GMP space dedicated to the production of oral contraceptives. This includes full-scale commercial production capabilities, including dispensing, granulation, compression, film coating and primary packaging, and has a potential output of 1.3 billion tablets. The new area will use abatement technology, which is used for the elimination of solvent emissions.

The dedicated space for oral contraceptive production fulfills a regulatory requirement needed to sell these products in many countries. This dedicated space also frees up manufacturing capacity in the Toronto facility for current and new business. The expanded Toronto site will be a Center of Excellence for Oral Contraceptives under the company’s proprietary Quick to Clinic program.

Terry Novak, president of Patheon North America, stated, “This expansion positions Patheon to compete on a higher level for contract manufacturing opportunities and claim a larger portion of the global oral contraceptive manufacturing market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters